首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1542879

全球中央血管通路设备市场 - 2024-2031

Global Central Vascular Access Devices Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球中央血管接取设备市场规模达17.4亿美元，预估至2031年将达28.2亿美元，2024-2031年预测期间复合年增长率为6.2%。

中央血管通路装置 (CVAD) 是专门的医疗工具，旨在实现静脉治疗、血液采样以及其他基本医疗程序的执行。

中心静脉接入装置 (CVAD)，也称为静脉接入端口或导管，是放置在患者大静脉中的薄、空心、柔性管，以允许频繁接入血流中的线。这些装置由外科医生或介入性放射科医生在使用或不使用全身麻醉的情况下插入。

CVAD 在当代医疗保健中至关重要，特别是对于接受化疗、长期抗生素治疗和全肠外营养等治疗的个人而言。这些设备经过精心设计，可长时间保持在原位，非常适合需要经常接触循环系统的患者。

市场动态：

司机

慢性病盛行率上升和技术进步

全球中央血管通路器械市场的需求受到多种因素的推动。主要因素之一是慢性病盛行率上升和技术进步。

心血管疾病（CVD）和慢性肾臟病（CKD）等慢性疾病的盛行率不断上升，是推动中央血管通路装置（CVAD）需求的主要因素。根据 NCBI 2023 年 11 月的研究出版物，慢性肾臟病 (CKD) 经常发生在糖尿病 (DM) 患者中，影响了约 40% 的患者。此外，DM 是心血管疾病 (CVD) 的重要危险因素，而 CKD 在调节这种风险方面发挥着至关重要的作用。

血管通路技术的进步，包括动力注射和抗菌导管的创建，正在提高这些设备的安全性和有效性。这些创新对于涉及高压注射的程序（例如影像研究）尤其重要。

此外，该行业的主要参与者更加关注血管设备的研究以及将推动该市场成长的伙伴关係和协作。例如，2023 年 6 月，Magenta Medical 启动了一项对其被认为是世界上最小的心臟帮浦的提升经皮左心室辅助装置 (pLVAD) 的早期可行性研究。

本研究旨在评估该装置在高风险经皮冠状动脉介入治疗 (HR-PCI) 手术期间最大限度地减少血管通路併发症的有效性。 Elevate 帮浦旨在提供临时机械循环支持，在这些关键干预措施期间提高病人安全和结果。透过使用较小的插入轮廓，该设备旨在降低与通常需要更多侵入性手术的传统较大帮浦相关的风险。

同样，2023 年3 月，美国外科医生学会(ACS) 和血管外科学会(SVS) 合作启动了血管验证计划(Vascular-VP)，这是一项国家品质验证计划，旨在改善结果并为患者提供最佳护理在住院环境中接受血管外科和介入治疗的患者。这项以证据为导向的标准化计划为医院建立和加强血管护理品质改善基础设施提供了一个框架。

限制

感染和併发症的风险、CVAD 的放置和维护的高成本以及产品召回和故障等因素预计将阻碍市场。

细分市场分析

全球中央血管通路装置市场根据类型、应用、最终用户和地区进行细分。

给药部分约占全球中央血管通路器械市场份额的48.2%

预计药物管理领域将在预测期内占据最大的市场份额。包括慢性肾臟病（CKD）和癌症在内的慢性疾病的盛行率不断上升，是推动药物管理领域发展的关键因素。根据 ScienceDirect 2024 年 2 月发表的研究报告，全球约有 700-8 亿人患有 CKD，推动了对中央血管通路器械市场的需求。

此细分市场的扩张主要是由于静脉注射 (IV) 疗法的需求不断增长，这对于提供全身性治疗至关重要，特别是对于慢性病患者。这些设备具有多种用途，包括给药、血液提取和液体输送，这使得它们成为临床环境中的适应性工具。根据患者的具体要求，它们可以透过颈静脉等中央插入，或在手臂外周插入。

此外，该行业的主要参与者推出了创新产品和技术开发，这将推动该细分市场在该市场的成长。例如，2023 年 10 月，B. Braun Medical Inc. 推出了具有多通道血液控制功能的新型 Introcan Safety 2 IV 导管。这项最新创新延续了贝朗对被动针刺预防的承诺。此导管不仅提供自动保护，防止针刺伤，还包括血液控制机制，可保护临床医生在每次访问针座时避免血液暴露。这项功能显着降低了静脉注射 (IV) 过程中接触血液传染病原体的风险。

同样，2023 年 12 月，贝朗推出了其创新的 CARESITE 微型鲁尔接取装置。该新产品旨在透过最大限度地减少有害化学物质的暴露并降低感染风险，提高患者和医疗保健专业人员静脉注射 (IV) 通路的安全性。

市场地域占有率

北美约占全球中央血管通路器械市场份额的43.4%

由于慢性病盛行率不断上升、技术进步、人口老化以及医疗设施的扩张推动了该地区的市场成长，预计北美地区将在预测期内占据最大的市场份额。

此外，大量关键参与者的存在、先进的医疗保健基础设施和产品发布将推动该市场的成长。例如，2023 年 11 月，BD 推出了 SiteRite 9 超音波系统，旨在提高临床医生放置各种血管通路装置的效率，包括週边插入中心静脉导管 (PICC) 和中心静脉导管。此先进系统具有用户友好的 15.6 吋触控萤幕和卓越的图像质量，为成功放置导管提供了必要的工具。

此外，Shockwave Medical, Inc. 于 2022 年 3 月宣布在获得 CE 标誌和 FDA 批准后，在全球推出 Shockwave M5+ 外周血管内碎石 (IVL) 导管。这种导管以前容量有限，经过专门设计，可以减少 IVL 手术的治疗时间，提供替代的通路选择，并将 IVL 治疗扩展到血管尺寸较大的患者。 Shockwave M5+ 导管的推出代表了严重钙化心血管疾病治疗的重大进步，提高了血管介入治疗的效率和效果。

此外，主要参与者的技术进步和产品批准推动了该市场的成长。例如，2023 年 11 月，BD 推出了新型 PIVOTM Pro 无针采血设备。这项创新解决方案已获得 FDA 510(k) 许可，旨在与整合的长外周 IV 导管配合使用，包括 BD 的 Nexiva 封闭式 IV 导管系统（具有 NearPort IV 通道）。

Central venous access devices (CVAD), also referred to as venous access ports or catheters are thin, hollow, flexible tubes placed in large veins of patients to allow frequent access to threads in the bloodstream. These devices are inserted either by surgeons or interventional radiologists with or without the use of general anesthesia.

CVADs are essential in contemporary healthcare, especially for individuals receiving treatments like chemotherapy, prolonged antibiotic therapy, and total parenteral nutrition. These devices are engineered to stay in place for prolonged durations, making them well-suited for patients who need frequent access to their circulatory system.

Market Dynamics: Drivers

Rising prevalence of chronic diseases & technological advancements

The demand for the global central vascular access devices market is driven by multiple factors. One of the primary factors is the rising prevalence of chronic diseases & technological advancements.

The growing prevalence of chronic illnesses, including cardiovascular diseases (CVDs) and chronic kidney disease (CKD), is a major factor fueling the demand for central vascular access devices (CVADs). According to an NCBI research publication in November 2023, chronic kidney disease (CKD) frequently occurs in individuals with diabetes mellitus (DM), affecting about 40% of these patients. Additionally, DM serves as a significant risk factor for cardiovascular disease (CVD), with CKD playing a crucial role in mediating this risk.

Advancements in vascular access technology, including the creation of power-injectable and antimicrobial catheters, are improving the safety and effectiveness of these devices. These innovations are particularly important for procedures that involve high-pressure injections, like imaging studies.

Moreover, key players in the industry more focus on research studies in vascular devices and partnerships & collaborations that would drive this market growth. For instance, in June 2023, Magenta Medical initiated an early feasibility study for its Elevate Percutaneous Left Ventricular Assist Device (pLVAD), recognized as the world's smallest heart pump.

This study aims to assess the device's effectiveness in minimizing vascular access complications during high-risk percutaneous coronary intervention (HR-PCI) procedures. The Elevate pump is designed to provide temporary mechanical circulatory support, enhancing patient safety and outcomes during these critical interventions. By using a smaller insertion profile, the device seeks to reduce the risks associated with traditional larger pumps that typically require more invasive procedures.

Similarly, in March 2023, the American College of Surgeons (ACS) and the Society for Vascular Surgery (SVS) collaborated to launch the Vascular Verification Program (Vascular-VP), a national quality verification initiative aimed at improving outcomes and delivering optimal care for patients receiving vascular surgical and interventional treatment in inpatient settings. This evidence-driven, standardized program provides a framework for hospitals to establish and enhance their vascular care quality improvement infrastructure.

Restraints

Factors such as the risk of infections & complications, high costs involved in the placement and maintenance of CVADs, and product recalls and failures are expected to hamper the market.

Market Segment Analysis

The global central vascular access devices market is segmented based on type, application, end-user, and region.

The drug administration segment accounted for approximately 48.2% of the global central vascular access devices market share

The drug administration segment is expected to hold the largest market share over the forecast period. The growing prevalence of chronic illnesses, including chronic kidney disease (CKD) and cancer, is a key factor propelling the drug administration segment. As per ScienceDirect research publication in February 2024, around 700-800 million individuals worldwide suffer from CKD, driving the demand for central vascular access devices market.

The expansion of this segment is primarily fueled by the increasing need for intravenous (IV) therapies, which are crucial for delivering systemic treatments, particularly for patients with chronic illnesses. These devices serve multiple purposes, including drug administration, blood extraction, and fluid delivery, which makes them adaptable tools in clinical environments. They can be inserted centrally, for example, via the jugular vein, or peripherally in the arm, based on the specific requirements of the patient.

Moreover, key players in the industry have innovative product launches and technological developments that would drive this segment's growth in this market. For instance, in October 2023, B. Braun Medical Inc. unveiled its new Introcan Safety 2 IV Catheter featuring Multi-Access Blood Control. This latest innovation continues B. Braun's commitment to passive needlestick prevention. The catheter not only provides automatic protection against needlestick injuries but also includes a blood control mechanism that safeguards clinicians from blood exposure each time the hub is accessed. This feature significantly reduces the risk of exposure to bloodborne pathogens during the intravenous (IV) process.

Similarly, in December 2023, B. Braun unveiled its innovative CARESITE Micro Luer Access Device. This new product aims to enhance the safety of intravenous (IV) access for both patients and healthcare professionals by minimizing exposure to harmful chemicals and reducing the risk of infection.

Market Geographical Share

North America accounted for approximately 43.4% of the global central vascular access devices market share

North America region is expected to hold the largest market share over the forecast period owing to the increasing prevalence of chronic diseases, technological advancements, aging population, and expansion of healthcare facilities driving this market growth in this region.

Moreover, a major number of key player's presence, well-advanced healthcare infrastructure, and product launches would drive this market growth. For instance, in November 2023, BD introduced the SiteRite 9 Ultrasound System, designed to enhance clinician efficiency in placing various vascular access devices, including peripherally inserted central catheters (PICCs) and central venous catheters. This advanced system features a user-friendly 15.6-inch touchscreen and superior image quality, providing essential tools for successful catheter placement.

Also, in March 2022, Shockwave Medical, Inc. announced the global launch of the Shockwave M5+ peripheral intravascular lithotripsy (IVL) catheter following its receipt of both CE Mark and FDA clearance. This catheter, which has previously been available in a limited capacity, is specifically engineered to reduce treatment times for IVL procedures, offer alternative access options, and extend IVL therapy to patients with larger vessel sizes. The introduction of the Shockwave M5+ catheter represents a significant advancement in the treatment of severely calcified cardiovascular disease, enhancing the efficiency and effectiveness of vascular interventions.

In addition, key player's technological advancements and product approvals driving this market growth. For instance, in November 2023, BD unveiled its new PIVOTM Pro Needle-free Blood Collection Device. This innovative solution, which received 510(k) clearance from the FDA, is designed to work with integrated and long peripheral IV catheters, including BD's Nexiva Closed IV Catheter System with NearPort IV Access.

Market Segmentation

By Type

Peripheral Inserted Central Catheter

Non-tunneled Catheters

Tunneled Catheters

Implanted Ports

By Application

Drug Administration

Parenteral Nutrition

Chemotherapy

Blood Transfusion

Diagnostics & Testing

By End-User

Hospitals

Specialty Clinics

Ambulatory Surgery Centers

Others

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the central vascular access devices market include B. Braun SE, Terumo Medical Corporation, Teleflex Incorporated, Access Vascular, Inc., BD, Cook, Medtronic, Baxter, Smith's Group plc (ICU Medical, Inc.), and AngioDynamics.

Key Developments

In May 2023, Teleflex announced the launch of two new devices aimed at improving peripherally inserted central catheter (PICC) insertion procedures and minimizing complications. The newly introduced Arrow VPS Rhythm DLX device and the NaviCurve stylet are designed to work in tandem, providing vascular access specialists with a more efficient and predictable method for PICC placement.

In June 2021, medK introduced a needle-free solution for vascular access. This innovative connection allows for safe and rapid access to fluid lines while eliminating the risk of needle stick injuries. The new device enhances safety for both healthcare professionals and patients by removing the need for traditional needle-based access methods.

Why Purchase the Report?

To visualize the global central vascular access devices market segmentation based on type, application, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the central vascular access devices market with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in excel consisting of key products of all the major players.

The global central vascular access devices market report would provide approximately 62 tables, 56 figures, and 181 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Prevalence of Chronic Diseases & Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Risk of Infections & Complications
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Peripheral Inserted Central Catheter*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Non-tunneled Catheters
6.4. Tunneled Catheters
6.5. Implanted Ports

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Drug Administration *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Parenteral Nutrition
7.4. Chemotherapy
7.5. Blood Transfusion
7.6. Diagnostics & Testing

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Ambulatory Surgery Centers
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. B. Braun SE *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Terumo Medical Corporation
11.3. Teleflex Incorporated
11.4. Access Vascular, Inc.
11.5. BD
11.6. Cook
11.7. Medtronic
11.8. Baxter
11.9. Smith's Group plc (ICU Medical, Inc.)
11.10. AngioDynamics (*LIST NOT EXHAUSTIVE)